Caladrius Biosciences, Inc. (CLBS) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 177 transactions totaling $427.5K, demonstrating a bullish sentiment with $122.9K in net insider flow. The most recent transaction on Sep 1, 2022 involved a transaction of 69,742 shares valued at $34.9K.
No significant insider buying has been recorded for CLBS in the recent period.
No significant insider selling has been recorded for CLBS in the recent period.
Based on recent SEC filings, insider sentiment for CLBS is bullish with an Insider Alignment Score of 64/100 and a net flow of $122.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Caladrius Biosciences, Inc. (CLBS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading CLBS stock, having executed 177 transactions in the past 90 days. The most active insider is David J. Mazzo (Executive), who has made 36 transactions totaling $939.3K.
Get notified when executives and directors at CLBS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | J. Mazzo David | Executive | Payment | 69,742 | $0.50 | $34.9K | |
| Sep 1, 2022 | J. Mazzo David | Executive | Award | 150,000 | $0.50 | $75.0K | |
| Sep 1, 2022 | K. Buck Kristen | Executive | Payment | 44,776 | $0.50 | $22.4K | |
| Sep 1, 2022 | K. Buck Kristen | Executive | Payment | 25,183 | $0.50 | $12.6K | |
| Sep 1, 2022 | K. Buck Kristen | Executive | Award | 58,000 | $0.50 | $29.0K | |
| Jan 14, 2022 | C. Girolamo Todd | Executive | Payment | 2,158 | $0.82 | $1.8K | |
| Jan 14, 2022 | J. Mazzo David | Executive | Payment | 6,611 | $0.82 | $5.4K | |
| Jan 13, 2022 | C. Girolamo Todd | Executive | Payment | 2,563 | $0.81 | $2.1K | |
| Jan 13, 2022 | J. Mazzo David | Executive | Payment | 6,471 | $0.81 | $5.2K | |
| Jan 11, 2022 | C. Girolamo Todd | Executive | Payment | 4,722 | $0.87 | $4.1K | |
| Jan 11, 2022 | J. Mazzo David | Executive | Payment | 16,740 | $0.87 | $14.6K | |
| Jan 10, 2022 | B. Brown Gregory | Executive | Award | 65,430 | $N/A | $0 | |
| Jan 10, 2022 | H. Davidson Michael | Executive | Award | 65,430 | $N/A | $0 | |
| Jan 10, 2022 | Louise Flowers Cynthia | Executive | Award | 65,430 | $N/A | $0 | |
| Jan 10, 2022 | M. Klosk Steven | Executive | Award | 65,430 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 91 | $1.5M | 51.3% |
Payment(F) | 72 | $1.0M | 34.2% |
Purchase(P) | 5 | $275.2K | 9.3% |
Sale(S) | 9 | $152.3K | 5.2% |
Insiders at Caladrius Biosciences, Inc. are accumulating shares at an accelerated pace. With 18 insiders making 177 transactions totaling $275.2K in purchases versus $152.3K in sales, the net buying activity of $122.9K signals strong executive confidence. David J. Mazzo (Executive) leads the buying activity with $939.3K in transactions across all time.